ROTH Capital initiated coverage on Bioceres with a new price target
$BIOX
Agricultural Chemicals
Industrials
ROTH Capital initiated coverage of Bioceres with a rating of Buy and set a new price target of $21.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/19/2024 | $17.00 | Buy | Canaccord Genuity |
| 7/2/2024 | $15.00 | Buy | ROTH MKM |
| 4/6/2023 | $15.00 | Outperform | Oppenheimer |
| 9/30/2022 | $22.50 | Buy | Canaccord Genuity |
| 10/8/2021 | $21.00 | Buy | ROTH Capital |
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Biostax Corp (OTC:BIOX) ("Biostax" or "the Company"), a biopharmaceutical company focused on developing innovative immune restoration therapies, today announced its Board of Directors has approved and the Company intends to proceed with the voluntary delisting of its common stock from the OTC Pink marketplace. This strategic decision follows strong shareholder support, with 76.4% voting in favor of the delisting through a Joint Written Consent. The Company plans to file a Form 25 with the Securities and Exchange Commission (SEC) on March 15, 2025, initiating the delisting process. The delisting is expected to become effective ten days a
Total revenues in 2Q25 were $106.7 million 2Q25 net income was $0.6 million and Adjusted EBITDA1 was $15.4 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal second quarter ended December 31, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Revenues in
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) today provided preliminary revenues, gross profit and adjusted EBITDA for the fiscal second quarter, ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million, with gross profit of $45 million and adjusted EBITDA of $15 million. These results reflect challenging conditions in Argentina, which remains a decisive market for the financial performance of the company in the first half of the year. Farmer purchasing behavior in the country changed significantly compared to the prior year, driven by macroeconomic conditions and unfavorable weather. This, together with high channel inventories, led to lower crop prot
Canaccord Genuity resumed coverage of Bioceres with a rating of Buy and set a new price target of $17.00
ROTH MKM resumed coverage of Bioceres with a rating of Buy and set a new price target of $15.00
Oppenheimer initiated coverage of Bioceres with a rating of Outperform and set a new price target of $15.00
Total revenues in 2Q25 were $106.7 million 2Q25 net income was $0.6 million and Adjusted EBITDA1 was $15.4 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal second quarter ended December 31, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Revenues in
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) today provided preliminary revenues, gross profit and adjusted EBITDA for the fiscal second quarter, ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million, with gross profit of $45 million and adjusted EBITDA of $15 million. These results reflect challenging conditions in Argentina, which remains a decisive market for the financial performance of the company in the first half of the year. Farmer purchasing behavior in the country changed significantly compared to the prior year, driven by macroeconomic conditions and unfavorable weather. This, together with high channel inventories, led to lower crop prot
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Wednesday, February 12, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal second quarter ended December 31, 2024. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and
SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
424B3 - Bioceres Crop Solutions Corp. (0001769484) (Filer)